Blog · Hearing aids← The news desk

✦ The Dispatch

Ear device patents for June 2026

A dispatch from Hearing Health Matters — filed

Woman placing a small hearing device in her ear, surrounded by logos of hearing and audio technology companies including GN, Sonova, Oticon, and others.
✦ PlateWoman placing a small hearing device in her ear, surrounded by logos of hearing and audio technology companies including GN, Sonova, Oticon, and others.

Hall Monitors Sonova and GN Hearing patents monitor and control user activity while performing hearing aid functions. GN Hearing patent #12659743, Third-party control of hearing device , takes on the Wild West of OEM devices that license GN architecture....

Continue reading at Hearing Health Matters

✦ The floor

Discussion

Signed responses from readers of the wire.

Clinical Takeaway

No actionable change — patent filings signal possible future product directions but have no immediate impact on clinical practice.

Why It Matters

These filings hint at the industry's push toward hearing aids that double as health-monitoring wearables and open-platform licensing ecosystems, which could reshape the competitive landscape over the next several years.

Key Points
  1. 01June 2026 patent roundup covers Sonova and GN Hearing filings.
  2. 02GN patent #12659743 describes hearing aids capable of monitoring and controlling user activity.
  3. 03A separate GN filing outlines a mechanism for third-party OEM control of licensed GN device architectures.
  4. 04Patents indicate a trend toward hearing aids functioning as multifunctional health-tracking wearables.
  5. 05No products have been launched or cleared; patents do not guarantee commercialisation.
Claims & Evidence

GN patent #12659743 describes hearing aids that can monitor and control user activity.

press releasepartially supported

GN has filed a patent covering third-party OEM control of licensed GN device architectures.

press releasepartially supported
Related stories